학술논문
Mosunetuzumab Monotherapy Demonstrates Durable Efficacy with a Manageable Safety Profile in Patients with Relapsed/Refractory Follicular Lymphoma Who Received >= 2 Prior Therapies: Updated Results from a Pivotal Phase II Study
Document Type
Journal
Author
Bartlett, Nancy L.; Sehn, Laurie H.; Matasar, Matthew J.; Schuster, Stephen J.; Assouline, Sarit; Giri, Pratyush; Kuruvilla, John; Canales, Miguel; Dietrich, Sascha; Fay, Keith; Ku, Matthew; Nastoupil, Loretta J.; Wei, Michael C.; Yin, Shen; To, Iris; Huang, Huang; Min, Juliana; Penuel, Elicia; Budde, L. Elizabeth
Source
Subject
Language
English
ISSN
15280020